Pfizer PFE
NYSE PFE
$29.33 +0.10 (+0.36%)
As of: Nov 10, 2026 · 3:59 PM EST

Pfizer (PFE) Construction in Progress (2009 - 2013)

Updated

Pfizer (PFE) reported Construction in Progress of $1.1 billion for Q4 2013, up 15.2% from $957 million a year earlier.

Analysis

Pfizer (PFE) Construction in Progress (2009 - 2013) Analysis & Trends

Dating back to Q4 2009, Pfizer's Construction in Progress record includes 5 quarters.

  • Construction in Progress has a four-year compound annual growth rate of -13.5% (FY2009 to FY2013).
  • By year, Construction in Progress came in at $957 million in FY2012 (-26.0%), $1.29 billion in FY2011 (+29.5%), $999 million in FY2010 (-49.2%) and $1.97 billion in FY2009.
  • The Q4 2013 figure ranks as the highest quarterly Construction in Progress since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 1.10 Bn
Dec 31, 2012 957.00 Mn
Dec 31, 2011 1.29 Bn
Dec 31, 2010 999.00 Mn
Dec 31, 2009 1.97 Bn
API Access

Pfizer Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=PFE&period=max&api_key=YOUR_API_KEY